SOPHiA GENETICS Balance Sheet Health
Financial Health criteria checks 4/6
SOPHiA GENETICS has a total shareholder equity of $113.5M and total debt of $13.2M, which brings its debt-to-equity ratio to 11.6%. Its total assets and total liabilities are $177.6M and $64.1M respectively.
Key information
11.6%
Debt to equity ratio
US$13.16m
Debt
| Interest coverage ratio | n/a |
| Cash | US$95.79m |
| Equity | US$113.51m |
| Total liabilities | US$64.10m |
| Total assets | US$177.61m |
Recent financial health updates
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Recent updates
Is SOPHiA GENETICS (NASDAQ:SOPH) A Risky Investment?
Oct 03SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target
Aug 09Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)
Aug 08SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 09Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
Feb 12Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 27Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge
Nov 09Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?
Aug 08Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Dec 15SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies
Sep 21SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
Aug 09We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely
Jul 01SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 18We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
Mar 10Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation
Nov 24Financial Position Analysis
Short Term Liabilities: SOPH's short term assets ($117.2M) exceed its short term liabilities ($30.9M).
Long Term Liabilities: SOPH's short term assets ($117.2M) exceed its long term liabilities ($33.2M).
Debt to Equity History and Analysis
Debt Level: SOPH has more cash than its total debt.
Reducing Debt: Insufficient data to determine if SOPH's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SOPH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SOPH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.